Lytix Biopharma AS (FRA:6BG)
Germany · Delayed Price · Currency is EUR 0.8720
+0.0180 (2.11%)
At close: Nov 28, 2025
Lytix Biopharma AS Market Cap
Lytix Biopharma AS has a market cap or net worth of €63.78 million as of December 1, 2025. Its market cap has increased by 127.72% in one year.
Market Cap
63.78M
Enterprise Value
56.34M
Revenue
32.17K
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.87
Market Cap Chart
Since June 14, 2021, Lytix Biopharma AS's market cap has decreased from 71.47M to 63.78M, a decrease of -10.76%. That is a compound annual growth rate of -2.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 1, 2025 | 63.78M | 87.51% |
| Dec 30, 2024 | 34.01M | 95.78% |
| Dec 29, 2023 | 17.37M | -41.17% |
| Dec 30, 2022 | 29.53M | -44.70% |
| Dec 30, 2021 | 53.40M | -25.28% |
| Jun 14, 2021 | 71.47M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 242.88B |
| Siemens Aktiengesellschaft | 176.79B |
| Allianz SE | 141.56B |
| Deutsche Telekom AG | 132.19B |
| Siemens Energy AG | 98.23B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 69.85B |
| Rheinmetall AG | 67.93B |
| Deutsche Bank Aktiengesellschaft | 58.37B |